D.Y. Patil Medical College, Hospital & Research Centre, India
Keynote: J Nephrol Ther
Introduction: Monoclonal Gammopathy of Undetermined Significance (MGUS) is consistent with immunoglobulin precipitation or deposition diseases occurring with B cell proliferation. Diagnostic features: Proteinuria (>60% nephrotic range), Microscopic hematuria (>65%), Hypertension (>50%), Renal insufficiency, ANA Positive-Speckled pattern (19%). Electron microscopy reveals 10-30 nm micro fibrils with random orientation in mesangium and glomerular capillary wall . Case Report: A 36 years old male, presented with history of generalized weakness, nausea, reduced appetite and reduced urine output since two months. Hemodialysis was initiated in view of progressive renal dysfunction and underwent kidney biopsy. Autoimmune work up was not significant. Diagnosis of dense deposit disease was made. Steroids started at 40 mg OD and tapered by 5 mg weekly. Hemodialysis (HD) sessions advised thrice a week through left femoral uncuffed nontunnelled HD catheter. Left brachiocephalic arteriovenous fistula was created. Patient came for kidney transplant work up to our center with wife as a prospective donor. He was admitted for further work up. His biopsy was reviewed. Free kappa/lambda ratio of 28.38 (0.26-1.65). Biopsy Impression was: (1) Widespread effacement/loss of visceral epithelial foot processes. (2) Massive mesangial accumulation of intermediate electron dense deposits with fine granular/short fibrillary appearance. Diagnosed as a case of chronic kidney disease/stage V/ fibrillary glomerulonephritis. At present patient is asymptomatic and on thrice a week HD at our center. Patient underwent 6 cycles of Bortezomib and Dexamethasone (once a week regimen). His initial serum creatinine was 10.8 mg/dl and now it had come down to 4.5 mg/dl. Repeat kappa/lambda ratio is 7.78.
Pratik shete has experience in the field of Nephrology and completed his education in D Y Patil Medical college ,India
E-mail: [email protected]
Journal of Nephrology & Therapeutics received 708 citations as per Google Scholar report